Laura E. Johnson
University of Wisconsin–Madison
ORCID: 0000-0002-1277-2636Also affiliated with University of Wisconsin Carbone Cancer Center
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 4 papers. Top paper: “Phase 2 trial of T-cell activation using MVI-816 and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC)”.
Jens C. Eickhoff, Ellen Wargowski, Laura E. Johnson, Christos E. Kyriakopoulos, Hamid Emamekhoo +4 more
Hamid Emamekhoo, Jens C. Eickhoff, Christos E. Kyriakopoulos, Ellen Wargowski, Tommaso P Tonelli +3 more
Donghwan Jeon, Laura E. Johnson, Jena E. Moseman, Anusha Muralidhar, Hemanth K. Potluri +5 more
Jens C. Eickhoff, Laura E. Johnson, Glenn Liu, Douglas G. McNeel, Tommaso P Tonelli